Prognosis
Finland to Exclude Johnson & Johnson From Covid-Vaccine Program
This article is for subscribers only.
Finland will exclude Johnson & Johnson from its Covid-19 inoculation program due to the risk of blood clots associated with adenovirus-vector vaccines.
The AstraZeneca adenovirus-vector vaccine that’s currently part of the country’s immunization program will only be given to people over 65, the Finnish Institute for Health and Welfare said on Tuesday. People under 65 who have already received their first Astra shot will be offered Pfizer or Moderna mRNA for their second dose.